Conference abstractPublished 20 Nov 2017
Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation
Griffith University, Australia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Rituximab impedes natural killer (NK) cells function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) patients: A pilot in vitro investigation outlines the toxicological effect Rituximab has on the cytotoxic activity of NK cells isolated from CFS/ME patients. CFS/ME is a multifactorial disorder commonly characterised by reduced NK cell cytotoxicity. A total of 8 CFS/ME patients (48.63 ± 15.69 years) and 9 non-fatigued controls (NFC) (37.56 ± 11.06 years) were included using the Fukuda case definition. Apoptotic function, lytic proteins (granzyme A and granzyme B) and degranulation markers (CD107a and CD107b) were measured on NK cells using flow cytometric analysis prior to and following overnight incubation with Rituximab at 10µg/ml and 100µg/ml. We reported a significant reduction in NK cell lysis of target K562 cells in CFS/ME patients compared to NFC following incubation with 100µg/ml of Rituximab (p<0.05). Conversely, no significant difference was reported for NFC following incubation with Rituximab. There was also a significant decrease in granzyme B in CFS/ME patients compared to NFC with 100µg/ml of Rituximab prior to K562 cells stimulation (p<0.05). Moreover, a significant increase in CD107a (p<0.05) and CD107b (p<0.01) expression was observed in NFC after stimulation with K562 cells prior to incubation with Rituximab. There was a significant increase in CD107b expression in CFS/ME patients before and after overnight incubation with 100µg/ml of Rituximab prior to K562 cells stimulation (p<0.01). This study showed that Rituximab can have significant impairment on NK cell activity and finally the toxicological effects may worsen patients’ symptoms.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Natalie Eaton”